Exploring the NANOG-TET2 interaction interface. Effects of a selected mutation and hypothesis on the clinical correlation with anemias
In this study, we focused on the computational analysis of a selected single-point mutation identified by a NGS screening panel in the TET2 enzyme classified as “variant of uncertain clinical significance.” The mutation, namely Q1084P, occurs at the interface between TET2, an important epigenetic re...
Saved in:
Main Authors: | Claudia Testi, Roberta Piacentini, Alessandro Perrone, Chiara Bartoli, Daniele Leso, Domitilla Pavia, Elisa Pistolesi, Flavio Scipione, Irene Cotronea, Marco Adinolfi Falcone, Marco Ierani, Alberto Boffi, Lorenzo Di Rienzo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Chemical Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fchbi.2024.1517163/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PAX6 enhances Nanog expression by inhibiting NOTCH signaling to promote malignant properties in small cell lung cancer cells
by: Xiao-Fang Guo, et al.
Published: (2025-01-01) -
Nr5a2 promotes cancer stem cell properties and tumorigenesis in nonsmall cell lung cancer by regulating Nanog
by: Ting Ye, et al.
Published: (2019-03-01) -
AMPK Activation in TET2 Downregulated Leukemia Cells Upon Glutamine Limitation
by: Ahsen Merve BAYRAK, et al.
Published: (2024-09-01) -
TET2-mediated 5-hydroxymethylcytosine of TXNIP promotes cell cycle arrest in systemic anaplastic large cell lymphoma
by: Ziqing Yu, et al.
Published: (2025-01-01) -
DNA去甲基化酶TET在神经母细胞瘤患者中表达及意义
by: 杨洋, et al.
Published: (2022-01-01)